‘Benefits outweigh risk’: UK agency on Covid vaccine approval

Updated on Dec 02, 2020 10:45 PM IST
Copy Link

The United Kingdom agency which cleared the Pfizer-BioNTech vaccine for public inoculation addressed doubts given the expedited nature of approval. UK gave its nod for the vaccine on December 2 with rollout expected from next week. Chief Executive of the Medicines and Healthcare Products Regulatory Agency, Dr June Raine, said that strict guidelines were adhered to, and the public has nothing to fear. Saying that benefits of the vaccine outweigh risks, she extolled the virtues of a 'rolling review' which ensured that a vaccine is made available to the public soon after successful trials. Watch the full video for more.

Story Saved
Saved Articles
My Reads
Sign out
New Delhi 0C
Tuesday, January 25, 2022